1Division of Cardiovascular Medicine, Electrophysiology Section, State University of New York: Downstate Medical Center, Brooklyn, New York, United States- 11203
2Department of Internal Medicine, State University of New York: Downstate Medical Center, Brooklyn, New York, United States- 11203
3Division of Hospital Medicine, Department of Medicine, Mount Sinai Beth Israel, Icahn School of Medicine NY, NY 10003
American Journal of Medical Case Reports.
2021,
Vol. 9 No. 4, 249-252
DOI: 10.12691/ajmcr-9-4-11
Copyright © 2021 Science and Education PublishingCite this paper: Ahmad Jallad, Andrew V. Doodnauth, Justin Lee, Emmanuel Valery, Stephanie Myers, Dahlia Rizk, Samy I. McFarlane. New Onset, Irreversible, Prolonged QT-Interval Requiring Permanent Biventricular Pacemaker in a COVID-19 Patient.
American Journal of Medical Case Reports. 2021; 9(4):249-252. doi: 10.12691/ajmcr-9-4-11.
Correspondence to: Samy I. McFarlane, Department of Internal Medicine, State University of New York: Downstate Medical Center, Brooklyn, New York, United States- 11203. Email:
Smcfarlane@downstte.eduAbstract
Various electrocardiographic (EKG) manifestations have been reported in patients with coronavirus disease 2019 (COVID-19). There is growing evidence showing that new onset QT-prolongation is a common EKG finding in COVID-19 patients. In this report, we present a case of a 71-year-old man who was found to have a new onset, irreversible, prolonged QT-interval requiring permanent biventricular pacemaker despite testing negative twice for RT-PCR COVID-19 and correction of all known reversible causes. To date, there are a limited number of reports of irreversible QT-prolongation associated with COVID-19. This case report emphasizes the importance of a physician's clinical judgment in the setting of negative RT-PCR COVID-19 testing. A robust systemic inflammatory state seen in active COVID-19 infection is possibly the key mechanism precipitating the new EKG findings.
Keywords